Total Funding
89
42
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
146291
Allergy Therapeutics (AT) is a European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy.
- Martin Hopcroft: Interim Chief Financial Officer
- Helge Weiner-Trapness: Chief Strategy OfficerPast Role: HSBC, Vice Chairman of Global Banking
About the Company
They have provided general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy), the only treatment to deal with the underlying cause and not just the
symptoms!
